These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24111560)

  • 21. Development and implementation challenges of a quality assured HIV infant diagnosis program in Nigeria using dried blood spots and DNA polymerase chain reaction.
    Audu R; Onwuamah C; Salu O; Okwuraiwe A; Ou CY; Bolu O; Bond KB; Diallo K; Lu L; Jelpe T; Okoye M; Ngige E; Vertefeuille J
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):433-8. PubMed ID: 25381805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
    Briz V; García D; Méndez-Lagares G; Ruiz-Mateos E; de Mulder M; Moreno-Pérez D; Navarro ML; León-Leal JA; de José MI; Ramos JT; Mellado MJ; González-Tomé MI; Leal M; Muñoz-Fernández MA
    Pediatr Infect Dis J; 2012 Oct; 31(10):1048-52. PubMed ID: 22828644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
    Symons J; van Lelyveld SF; Hoepelman AI; van Ham PM; de Jong D; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2011 Apr; 66(4):890-5. PubMed ID: 21393136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1.
    Parczewski M; Leszczyszyn-Pynka M; Urbanska A; Bander D; Boron-Kaczmarska A
    J Med Virol; 2011 Nov; 83(11):1869-75. PubMed ID: 21915859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing.
    Brooks K; DeLong A; Balamane M; Schreier L; Orido M; Chepkenja M; Kemboi E; D'Antuono M; Chan PA; Emonyi W; Diero L; Coetzer M; Kantor R
    J Clin Microbiol; 2016 Jan; 54(1):223-5. PubMed ID: 26560534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand.
    Leelawiwat W; Young NL; Chaowanachan T; Ou CY; Culnane M; Vanprapa N; Waranawat N; Wasinrapee P; Mock PA; Tappero J; McNicholl JM
    J Virol Methods; 2009 Feb; 155(2):109-17. PubMed ID: 18952125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint.
    McGovern RA; Symons J; Poon AF; Harrigan PR; van Lelyveld SF; Hoepelman AI; van Ham PM; Dong W; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2013 Sep; 68(9):2007-14. PubMed ID: 23677920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low risk of contamination with automated and manual excision of dried blood spots for HIV DNA PCR testing in the routine laboratory.
    Driver GA; Patton JC; Moloi J; Stevens WS; Sherman GG
    J Virol Methods; 2007 Dec; 146(1-2):397-400. PubMed ID: 17854915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for cross-contamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotyping.
    Buckton AJ; Prabhu DP; Cane PA; Pillay D
    J Antimicrob Chemother; 2009 Mar; 63(3):615-6. PubMed ID: 19158111
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study.
    Yapo V; d'Aquin Toni Td; Desmonde S; Amani-Bosse C; Oga M; Lenaud S; Menan H; Timité-Konan M; Leroy V; Rouzioux C
    J Virol Methods; 2013 Nov; 193(2):439-45. PubMed ID: 23872283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C; Charpentier C; Flandre P; Nino C; Carcelain G; Simon A; Katlama C; Landman R; Brun-Vézinet F; Descamps D; Calvez V; Marcelin AG
    J Med Virol; 2012 Dec; 84(12):1853-6. PubMed ID: 23080487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel RealTime HIV-1 Qualitative assay for the detection of HIV-1 nucleic acids in dried blood spots and plasma.
    Huang S; Erickson B; Mak WB; Salituro J; Abravaya K
    J Virol Methods; 2011 Dec; 178(1-2):216-24. PubMed ID: 21968095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A nested multiplex PCR assay for rapid subtyping the prevailing HIV-1 strains in Guangxi].
    Su QJ; Zhou P; Bi ZY; Xiao X; Wu SZ; Cen P; Deng W; Shao YM; Liang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):482-4. PubMed ID: 20718364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variability in HIV viral tropism determination using different genotypic algorithms in patients infected with B versus non-B HIV-1 subtypes].
    Rodríguez JJ; Seclén E; Poveda E; Varela E; Regueiro B; Aguilera A
    Enferm Infecc Microbiol Clin; 2011 Jan; 29(1):4-8. PubMed ID: 21310511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of dried plasma HIV-1 viral load testing in Brazil using ViveST for sample collection.
    Zanoni M; Cortes R; Diaz RS; Sucupira MC; Ferreira D; Inocencio LA; Vilhena C; Loveday C; Lloyd RM; Holodniy M
    J Clin Virol; 2010 Dec; 49(4):245-8. PubMed ID: 20880740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.
    Symons J; Vandekerckhove L; Paredes R; Verhofstede C; Bellido R; Demecheleer E; van Ham PM; van Lelyveld SF; Stam AJ; van Versendaal D; Nijhuis M; Wensing AM
    Clin Microbiol Infect; 2012 Jun; 18(6):606-12. PubMed ID: 21906210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.